Axsome Secures FDA Approval for Alzheimer’s Agitation Treatment, Marking Major Milestone in Neurotherapeutics
Axsome Therapeutics has received FDA approval for its Alzheimer’s agitation drug, marking a significant advancement in neurotherapeutic treatments. Th...
